AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer

David S. Hong, A. Robert MacLeod, Samantha J. Lee et al.|Science Translational Medicine|2015

Cited by 438